The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) – Joseph Gehrett, MD; Barbara Gehrett, MD; Chris Flowers, MD; and Loree Britt – produced an shocking review of anaphylaxis (severe allergy reaction) adverse events found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 […]
NAATs Used in Pfizer Clinical Trial to Test Asymptomatic Patients Despite Not Being Approved (or Even Emergency Use Authorized) for Asymptomatic Testing.
Nasal swab nucleic acid amplification tests (NAATs) are “a type of viral diagnostic test for SARS-CoV-2, the virus that causes COVID-19.” [https://www.cdc.gov/coronavirus/2019-ncov/lab/naats.html and https://www.fda.gov/consumers/consumer-updates/covid-19-test-basics] Although certain NAAT tests have now been authorized for emergency use (EUA) for screening purposes (in asymptomatic persons), the three NAAT tests used at the time […]
Report 60: 449 Patients Suffer Bell’s Palsy Following Pfizer mRNA COVID Vaccination in Initial Three Months of Rollout. A One-Year-Old Endured Bell’s Palsy After Unauthorized Injection.
The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) – Joseph Gehrett, MD; Barbara Gehrett, MD; Chris Flowers, MD; and Loree Britt – produced a disturbing review of the Facial Paralysis System Organ Class (SOC) adverse events found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse […]
Report 52: Nine Months Post-COVID mRNA “Vaccine” Rollout, Substantial Birth Rate Drops in 13 European Countries, England/Wales, Australia, and Taiwan.
Robert W. Chandler, MD, completed extensive research to write the article below. Some of the highlights of this important piece include: Nine months following the rollout of the COVID-19 mRNA “vaccines,” substantial birth rate drops were seen in 13 of 19 European countries, England and Wales (one entity based on how […]
Pfizer/BioNTech Trial – A failed yet in depth attempt to reproduce the NEJM & FDA efficacy figures
Study version 1.3, published on 2022-12-09 To view the full version with graphics, please click here. Introduction We review, in this article, a list of problems in the Pfizer/BioNTech C4591001 Trial, which came out in our attempts to reproduce the results provided by the study. Using the sponsor’s data communicated to […]
“170 Patients That Changed Everything” – Spectator | Australia
Few people realise that the Emergency Use Authorisation (EUA) of the Pfizer-BioNTech Covid-19 Vaccine/BNT162b2 was granted on the efficacy data of 170 patients. The 162 who received a placebo and 8 patients who were vaccinated formed the basis of the 95 per cent efficacy claims. There has not been much […]